India to start trials on safety, efficacy of mixing vaccine doses

India will soon start trials to test the safety, immunogenicity and efficacy after mixing doses of different brands of Covid-19 vaccines. While the trials will currently include Covaxin, Covishield and Sputnik-V, which currently have emergency use authorisation in the country, going forward the trials may also include jabs that are in the pipeline, senior officials said.